We analyzed the density, quality, and temporal distribution of tumor-infiltrating immune cells (CD3+, CD4+, CD8+, Foxp3+, and CD57+), as well as molecular and immunophenotypic biomarkers of tumor immunogenicity, along the development of colorectal precursor and invasive lesions. This evidence concerns the gene CD4 and neoplasm.